BackFirst Wave BioPharma Overview

First Wave BioPharma Current Cash

First Wave BioPharma's current cash is $1.4M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$1.38M
↑ 30738.65% YoYΔ $1.38M vs prior year quarter

Peer trimmed avg / median

Loading

First Wave BioPharma Current Cash History

Loading

First Wave BioPharma vs. peers: Current Cash Comparison

Loading

First Wave BioPharma Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

First Wave BioPharma (FWBI) FAQ

The latest current cash for FWBI is $1.4M as of June 2026. That compares with $4.5K in the prior-year period — up 30738.6% year over year. Investors often review this figure alongside First Wave BioPharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, FWBI's current cash moved from $4.5K to $1.4M — a 30738.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in First Wave BioPharma's operating scale or balance-sheet position.

A current cash figure of $1.4M for FWBI is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting FWBI's current cash ($1.4M), review year-over-year change from $4.5K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack First Wave BioPharma's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.